Geneva, Switzerland – SOPHiA GENETICS, a cloud-native software company in the healthcare space, is embarking on a multi-year integrated partnership with Microsoft to improve healthcare workflows globally. This investment in the development of next- generation healthcare will lead the way in enabling multimodal data curation, development, and deployment. As a result, the Microsoft Azure-powered SOPHiA DDM platform is expected to elevate the standard of care for patients, by delivering advanced outcomes for precision medicine.
SOPHiA GENETICS’ global network breaks down data silos, allowing the democratisation of data-driven medicine by connecting institutions that leverage diverse multimodal data sets on the SOPHiA DDM platform. Multimodal health data sets can be the largest and most complex to structure, analyse and archive, and this wide-ranging partnership will focus on accelerating results, improving performance, and ultimately enhance medical research by propelling the transition to precision medicine globally.
“With Microsoft’s scale and the power of the SOPHiA DDM platform, this partnership will help improve clinical outcomes and make patient care more efficient and personalised,” says Jurgi Camblong, PhD., co-founder and CEO, SOPHiA GENETICS. “SOPHiA GENETICS will help accelerate the transition to a decentralised care model for hospitals, healthcare providers and biopharma by breaking down data silos and delivering innovation at scale.”
“SOPHiA GENETICS’ mission is to democratise data-driven medicine. Microsoft is pleased to support this mission by providing secure and scalable cloud infrastructure, alongside SOPHiA GENETICS’ advanced artificial intelligence and machine learning tools and technologies that can help generate actionable insights, which can lead to better health outcomes,” says David C. Rhew, M.D., global chief medical officer, Microsoft.
This partnership expands on SOPHiA GENETICS’ and Microsoft’s collaboration. SOPHiA GENETICS offers its AI and machine learning SOPHiA DDM platform on Azure, by leveraging various Azure services that enable greater efficiencies and open opportunities for advancing tools to unlock important medical and genomic data. With the addition of the SOPHiA DDM platform, providers utilising Azure will scale their ability to aggregate multimodal data types to extract insights within existing workflows for their pursuit to deliver the best care possible. As one of Microsoft’s chosen partners for precision medicine, SOPHiA GENETICS will help accelerate the transition to a decentralised care model for hospitals, healthcare providers and biopharma, by breaking down data solution at scale.
SOPHiA GENETICS products are for research use only and not for use in diagnostic procedures, unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
Follow us and Comment on Twitter @TheEE_io